Calithera Biosciences (NASDAQ:CALA) Earns Hold Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research note issued to investors on Monday. The firm issued a hold rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

Shares of Calithera Biosciences stock opened at $0.00 on Monday. Calithera Biosciences has a fifty-two week low of $0.00 and a fifty-two week high of $0.12.

Calithera Biosciences Company Profile

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.